Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11901
PUT
FingerMotion
FNGR
$9.91M
| $81K | ﹤0.01% |
39,900
+26,900
| +207% | +$66K |
|
|
OPTU
11902
PUT
Optimum Communications Inc
OPTU
$412M
| $80.9K | ﹤0.01% |
37,800
-1,800
| -5% | -$4.22K |
|
|
MFM
11903
Aberdeen Municipal Income Fund
MFM
$221M
| $80.9K | ﹤0.01% |
15,640
-4,839
| -24% | -$24.9K |
|
11904
CALL
Ampco-Pittsburgh
AP
$184M
| $80.8K | ﹤0.01% |
27,300
-58,300
| -68% | -$151K |
|
11905
Patriot National Bancorp
PNBK
$123M
| $80.7K | ﹤0.01% |
+53,121
| New | +$144K |
|
11906
Microbot Medical
MBOT
$102M
| $80.2K | ﹤0.01% |
31,839
-72,341
| -69% | -$173K |
|
|
CTNM
11907
Contineum Therapeutics
CTNM
$640M
| $79.9K | ﹤0.01% |
20,131
+6,874
| +52% | +$29.9K |
|
11908
PUT
Everspin Technologies
MRAM
$429M
| $79.9K | ﹤0.01% |
12,700
| – | – |
|
11909
CALL
Cullinan Oncology
CGEM
$1.47B
| $79.8K | ﹤0.01% |
10,600
-400
| -4% | -$3.21K |
|
|
GBIO
11910
DELISTED
Generation Bio
GBIO
| $79.8K | ﹤0.01% |
24,928
+15,703
| +170% | +$60.5K |
|
11911
Great Elm Group
GEG
$67.4M
| $79.8K | ﹤0.01% |
37,810
+4,643
| +14% | +$9.36K |
|
11912
inTEST
INTT
$146M
| $79.7K | ﹤0.01% |
10,947
-3,079
| -22% | -$19.5K |
|
|
DCX
11913
Digital Currency X Technology Inc
DCX
$306M
| $79.7K | ﹤0.01% |
+33
| New | +$72.2K |
|
11914
CALL
Pliant Therapeutics
PLRX
$71.8M
| $79.6K | ﹤0.01% |
68,600
-35,300
| -34% | -$49.9K |
|
11915
Air Industries Group
AIRI
$12.6M
| $79.5K | ﹤0.01% |
+23,648
| New | +$80.6K |
|
|
NNDM
11916
CALL
Nano Dimension
NNDM
$335M
| $79.4K | ﹤0.01% |
49,000
-971,900
| -95% | -$1.49M |
|
11917
PUT
Vera Bradley
VRA
$95.3M
| $79.1K | ﹤0.01% |
+35,800
| New | +$73.9K |
|
11918
StealthGas
GASS
$342M
| $79K | ﹤0.01% |
+12,331
| New | +$70.7K |
|
11919
PUT
PetMed Express
PETS
$38.8M
| $79K | ﹤0.01% |
23,800
+6,300
| +36% | +$22.4K |
|
11920
PUT
Krispy Kreme
DNUT
$597M
| $78.6K | ﹤0.01% |
27,000
+7,800
| +41% | +$27.2K |
|
11921
PUT
Neuronetics
STIM
$229M
| $78.2K | ﹤0.01% |
22,400
+5,700
| +34% | +$22.5K |
|
11922
PUT
CareCloud
CCLD
$112M
| $78.1K | ﹤0.01% |
+33,100
| New | +$62.9K |
|
|
PZC
11923
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $78.1K | ﹤0.01% |
+12,531
| New | +$78.6K |
|
11924
CALL
Scilex Holding
SCLX
$39.5M
| $77.7K | ﹤0.01% |
+13,200
| New | +$74.6K |
|
|
STKL
11925
PUT
DELISTED
SunOpta
STKL
| $77.7K | ﹤0.01% |
+13,400
| New | +$70.4K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.